Cargando…
Triple-negative breast cancer: current treatment strategies and factors of negative prognosis
Breast cancer is the most common cancer in women and the most common cause of death in working-age women. According to the results of immunohistochemical studies, 10–20% of cases revealed a triple-negative type of breast cancer. This subtype is characterized by significant proliferative activity and...
Autores principales: | Baranova, Anna, Krasnoselskyi, Mykola, Starikov, Volodymyr, Kartashov, Sergii, Zhulkevych, Igor, Vlasenko, Vadym, Oleshko, Kateryna, Bilodid, Olga, Sadchikova, Marina, Vinnyk, Yurii |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Carol Davila University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999097/ https://www.ncbi.nlm.nih.gov/pubmed/35419095 http://dx.doi.org/10.25122/jml-2021-0108 |
Ejemplares similares
-
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016) -
Clinical features and prognosis of triple-negative breast cancer
por: Sanz, M Izquierdo, et al.
Publicado: (2009) -
T-cadherin is associated with prognosis in triple-negative breast cancer
por: Kong, De-Di, et al.
Publicado: (2017) -
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
por: Ouyang, Mao, et al.
Publicado: (2015) -
A CLDN1-Negative Phenotype Predicts Poor Prognosis in Triple-Negative Breast Cancer
por: Ma, Fei, et al.
Publicado: (2014)